Annual Income Statements for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
Annual Income Statements for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table shows Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table shows Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Net Income / (Loss) Attributable to Common Shareholders |
|
9.99 |
7.63 |
8.09 |
6.75 |
0.90 |
-6.22 |
-1.35 |
0.77 |
-5.13 |
-18 |
4.64 |
Consolidated Net Income / (Loss) |
|
10 |
7.56 |
7.62 |
6.72 |
1.05 |
-6.36 |
-1.28 |
0.65 |
-5.28 |
-19 |
5.40 |
Net Income / (Loss) Continuing Operations |
|
11 |
8.69 |
7.82 |
6.96 |
-0.29 |
-5.45 |
-1.06 |
0.79 |
-4.10 |
-21 |
5.40 |
Total Pre-Tax Income |
|
11 |
8.02 |
6.97 |
7.91 |
6.30 |
-11 |
-0.10 |
2.41 |
-5.54 |
-16 |
7.73 |
Total Revenue |
|
12 |
26 |
11 |
12 |
23 |
21 |
22 |
29 |
29 |
32 |
44 |
Net Interest Income / (Expense) |
|
0.00 |
-0.04 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
Total Interest Income |
|
0.00 |
-0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
Total Interest Expense |
|
0.00 |
0.04 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
Total Non-Interest Income |
|
12 |
26 |
11 |
12 |
23 |
21 |
22 |
29 |
29 |
32 |
44 |
Other Non-Interest Income |
|
0.76 |
- |
0.61 |
0.71 |
4.39 |
-0.50 |
1.91 |
2.27 |
2.36 |
2.57 |
44 |
Total Non-Interest Expense |
|
0.84 |
16 |
2.86 |
3.13 |
15 |
21 |
19 |
22 |
21 |
50 |
23 |
Marketing Expense |
|
0.01 |
- |
0.73 |
0.68 |
1.70 |
1.79 |
1.93 |
2.55 |
2.17 |
2.41 |
2.62 |
Other Operating Expenses |
|
0.58 |
15 |
2.25 |
3.12 |
11 |
19 |
17 |
18 |
18 |
43 |
16 |
Depreciation Expense |
|
0.00 |
- |
0.00 |
0.00 |
1.69 |
1.71 |
1.68 |
1.75 |
1.75 |
2.73 |
4.76 |
Other Special Charges |
|
0.25 |
- |
-0.13 |
-0.67 |
0.31 |
-0.88 |
-1.16 |
0.36 |
-0.42 |
1.46 |
-0.27 |
Nonoperating Income / (Expense), net |
|
0.04 |
- |
-0.56 |
-0.46 |
-3.54 |
-9.06 |
-2.36 |
-4.36 |
-12 |
0.56 |
-13 |
Income Tax Expense |
|
0.35 |
- |
-0.66 |
1.18 |
1.71 |
-0.77 |
1.17 |
1.76 |
-0.25 |
2.80 |
2.33 |
Net Income / (Loss) Attributable to Noncontrolling Interest |
|
0.36 |
- |
-0.46 |
-0.03 |
0.15 |
-0.14 |
0.07 |
-0.12 |
-0.16 |
-0.75 |
0.76 |
Basic Earnings per Share |
|
$0.20 |
- |
$0.16 |
$0.13 |
$0.01 |
($0.13) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Weighted Average Basic Shares Outstanding |
|
50.37M |
50.37M |
50.37M |
50.51M |
63.35M |
56.95M |
63.03M |
63.85M |
74.69M |
70.76M |
96.19M |
Diluted Earnings per Share |
|
$0.20 |
- |
$0.16 |
$0.13 |
$0.01 |
($0.14) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Weighted Average Diluted Shares Outstanding |
|
50.37M |
50.37M |
50.37M |
50.51M |
63.35M |
57.77M |
63.03M |
67.16M |
74.69M |
70.76M |
97.50M |
Weighted Average Basic & Diluted Shares Outstanding |
|
18.34M |
0.00 |
11.48M |
62.96M |
63.35M |
63.69M |
63.93M |
74.65M |
74.68M |
96.85M |
96.85M |
Annual Cash Flow Statements for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table details how cash moves in and out of Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
30 |
-4.46 |
106 |
Net Cash From Operating Activities |
11 |
-64 |
-209 |
Net Cash From Continuing Operating Activities |
11 |
-64 |
-209 |
Net Income / (Loss) Continuing Operations |
32 |
9.03 |
-25 |
Consolidated Net Income / (Loss) |
32 |
9.03 |
-25 |
Depreciation Expense |
0.00 |
3.41 |
7.91 |
Amortization Expense |
0.00 |
0.04 |
0.94 |
Non-Cash Adjustments to Reconcile Net Income |
-3.72 |
-6.80 |
0.79 |
Changes in Operating Assets and Liabilities, net |
-18 |
-70 |
-194 |
Net Cash From Investing Activities |
-3.70 |
2.24 |
-4.96 |
Net Cash From Continuing Investing Activities |
-3.70 |
2.24 |
-4.96 |
Purchase of Property, Leasehold Improvements and Equipment |
0.00 |
-0.19 |
-0.79 |
Purchase of Investment Securities |
-0.80 |
-0.35 |
-3.65 |
Other Investing Activities, net |
-2.90 |
2.78 |
-0.52 |
Net Cash From Financing Activities |
23 |
57 |
320 |
Net Cash From Continuing Financing Activities |
23 |
57 |
320 |
Issuance of Debt |
30 |
124 |
198 |
Issuance of Common Equity |
- |
0.00 |
182 |
Repayment of Debt |
0.00 |
-26 |
-32 |
Repurchase of Common Equity |
0.00 |
-1.28 |
-11 |
Payment of Dividends |
-7.07 |
-24 |
-1.16 |
Other Financing Activities, Net |
0.00 |
-16 |
-16 |
Cash Interest Paid |
0.00 |
4.04 |
12 |
Cash Income Taxes Paid |
0.00 |
0.15 |
2.15 |
Quarterly Cash Flow Statements for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table details how cash moves in and out of Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Net Change in Cash & Equivalents |
|
1.00 |
26 |
-10 |
0.89 |
16 |
-11 |
40 |
26 |
-72 |
113 |
-88 |
Net Cash From Operating Activities |
|
-1.64 |
17 |
-17 |
-21 |
-12 |
-14 |
2.27 |
-67 |
-52 |
-92 |
-62 |
Net Cash From Continuing Operating Activities |
|
-1.64 |
17 |
-17 |
-21 |
-12 |
-14 |
2.27 |
-67 |
-52 |
-92 |
-62 |
Net Income / (Loss) Continuing Operations |
|
10 |
10 |
7.62 |
6.72 |
1.05 |
-6.36 |
-1.28 |
0.65 |
-5.28 |
-19 |
5.40 |
Consolidated Net Income / (Loss) |
|
10 |
10 |
7.62 |
6.72 |
1.05 |
-6.36 |
-1.28 |
0.65 |
-5.28 |
-19 |
5.40 |
Depreciation Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
1.69 |
1.71 |
1.68 |
1.75 |
1.75 |
2.73 |
4.76 |
Amortization Expense |
|
- |
- |
0.00 |
- |
0.13 |
-0.09 |
0.09 |
0.36 |
0.19 |
0.30 |
0.49 |
Non-Cash Adjustments to Reconcile Net Income |
|
-57 |
61 |
-1.02 |
-0.45 |
-4.75 |
-0.58 |
5.39 |
-5.93 |
-3.02 |
4.34 |
-71 |
Changes in Operating Assets and Liabilities, net |
|
45 |
-54 |
-24 |
-27 |
-9.99 |
-8.49 |
-3.63 |
-64 |
-46 |
-80 |
-1.74 |
Net Cash From Investing Activities |
|
-1.68 |
-1.77 |
-1.00 |
-6.06 |
9.63 |
-0.33 |
-0.01 |
-0.71 |
-0.45 |
-3.79 |
-3.74 |
Net Cash From Continuing Investing Activities |
|
-1.68 |
-1.77 |
-1.00 |
-6.06 |
9.63 |
-0.33 |
-0.01 |
-0.71 |
-0.45 |
-3.79 |
-3.74 |
Purchase of Property, Leasehold Improvements and Equipment |
|
- |
- |
0.00 |
- |
-0.10 |
-0.09 |
-0.16 |
-0.19 |
-0.24 |
-0.19 |
-0.22 |
Purchase of Investment Securities |
|
- |
-0.55 |
-0.15 |
-0.15 |
-0.05 |
- |
-0.09 |
-0.11 |
-0.10 |
-3.35 |
-3.52 |
Net Cash From Financing Activities |
|
4.33 |
11 |
8.05 |
28 |
18 |
3.08 |
38 |
93 |
-19 |
208 |
-23 |
Net Cash From Continuing Financing Activities |
|
4.33 |
11 |
8.05 |
28 |
18 |
3.08 |
38 |
93 |
-19 |
208 |
-23 |
Issuance of Debt |
|
3.44 |
17 |
8.05 |
52 |
27 |
37 |
43 |
9.03 |
15 |
132 |
16 |
Repayment of Debt |
|
- |
- |
- |
- |
- |
-26 |
- |
- |
- |
- |
-39 |
Repurchase of Common Equity |
|
- |
- |
0.00 |
- |
- |
-1.28 |
-7.52 |
-3.22 |
- |
- |
0.00 |
Other Financing Activities, Net |
|
1.82 |
-2.50 |
0.00 |
-0.69 |
-8.74 |
-6.10 |
2.14 |
-3.19 |
-1.68 |
-13 |
-0.47 |
Cash Interest Paid |
|
- |
- |
0.00 |
0.77 |
0.56 |
2.71 |
1.69 |
2.94 |
3.22 |
3.76 |
5.37 |
Cash Income Taxes Paid |
|
- |
- |
0.00 |
- |
- |
0.15 |
0.00 |
2.69 |
- |
-0.55 |
0.00 |
Annual Balance Sheets for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table presents Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Total Assets |
59 |
332 |
874 |
Cash and Due from Banks |
30 |
26 |
132 |
Trading Account Securities |
1.89 |
3.45 |
2.21 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
Customer and Other Receivables |
0.00 |
1.01 |
1.53 |
Premises and Equipment, Net |
0.02 |
0.40 |
1.03 |
Goodwill |
0.00 |
140 |
238 |
Intangible Assets |
0.00 |
30 |
80 |
Other Assets |
27 |
131 |
419 |
Total Liabilities & Shareholders' Equity |
59 |
332 |
874 |
Total Liabilities |
31 |
168 |
451 |
Interest Bearing Deposits |
0.00 |
0.51 |
2.47 |
Short-Term Debt |
0.04 |
13 |
38 |
Accrued Interest Payable |
0.96 |
5.22 |
7.14 |
Other Short-Term Payables |
0.31 |
4.57 |
14 |
Long-Term Debt |
28 |
127 |
342 |
Other Long-Term Liabilities |
1.39 |
18 |
46 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
28 |
164 |
423 |
Total Preferred & Common Equity |
27 |
164 |
424 |
Preferred Stock |
0.00 |
0.00 |
0.00 |
Total Common Equity |
27 |
164 |
424 |
Common Stock |
0.71 |
200 |
494 |
Retained Earnings |
25 |
-35 |
-58 |
Treasury Stock |
0.00 |
-1.28 |
-12 |
Accumulated Other Comprehensive Income / (Loss) |
1.05 |
0.11 |
0.00 |
Noncontrolling Interest |
0.90 |
0.14 |
-0.86 |
Quarterly Balance Sheets for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table presents Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Total Assets |
|
100 |
30 |
277 |
304 |
377 |
484 |
477 |
857 |
Cash and Due from Banks |
|
1.67 |
0.06 |
21 |
37 |
65 |
91 |
19 |
44 |
Trading Account Securities |
|
- |
- |
1.00 |
1.00 |
4.66 |
5.17 |
4.20 |
2.74 |
Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Customer and Other Receivables |
|
- |
- |
0.08 |
1.00 |
- |
1.17 |
1.28 |
1.67 |
Premises and Equipment, Net |
|
- |
- |
0.18 |
0.26 |
0.55 |
0.69 |
0.89 |
1.18 |
Goodwill |
|
- |
- |
140 |
140 |
140 |
140 |
140 |
238 |
Intangible Assets |
|
- |
- |
33 |
31 |
28 |
26 |
25 |
75 |
Other Assets |
|
0.31 |
0.18 |
82 |
92 |
138 |
219 |
287 |
494 |
Total Liabilities & Shareholders' Equity |
|
100 |
30 |
277 |
304 |
377 |
484 |
477 |
857 |
Total Liabilities |
|
30 |
20 |
117 |
138 |
211 |
227 |
219 |
421 |
Interest Bearing Deposits |
|
- |
- |
0.98 |
0.35 |
0.67 |
1.44 |
0.92 |
0.60 |
Short-Term Debt |
|
4.92 |
5.58 |
0.40 |
0.00 |
16 |
46 |
14 |
118 |
Accrued Interest Payable |
|
7.94 |
10 |
1.12 |
0.89 |
2.32 |
2.47 |
5.14 |
3.27 |
Other Short-Term Payables |
|
- |
- |
11 |
4.22 |
5.19 |
5.71 |
3.66 |
8.83 |
Long-Term Debt |
|
- |
- |
91 |
119 |
170 |
151 |
167 |
238 |
Other Long-Term Liabilities |
|
17 |
4.15 |
12 |
14 |
17 |
20 |
29 |
52 |
Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Redeemable Noncontrolling Interest |
|
98 |
29 |
- |
- |
- |
- |
- |
5.00 |
Total Equity & Noncontrolling Interests |
|
-27 |
-20 |
160 |
166 |
165 |
257 |
258 |
431 |
Total Preferred & Common Equity |
|
-27 |
-20 |
160 |
166 |
165 |
257 |
258 |
431 |
Preferred Stock |
|
0.00 |
0.00 |
- |
- |
0.00 |
0.00 |
0.00 |
0.00 |
Total Common Equity |
|
-27 |
-20 |
160 |
166 |
165 |
257 |
258 |
431 |
Common Stock |
|
0.03 |
0.00 |
189 |
194 |
210 |
303 |
310 |
496 |
Retained Earnings |
|
-28 |
-20 |
-29 |
-29 |
-36 |
-35 |
-40 |
-53 |
Treasury Stock |
|
- |
- |
- |
- |
-8.81 |
-12 |
-12 |
-12 |
Noncontrolling Interest |
|
- |
- |
0.36 |
0.29 |
0.21 |
0.08 |
-0.09 |
-0.10 |
Annual Metrics And Ratios for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table displays calculated financial ratios and metrics derived from Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's official financial filings.
Metric |
2022 |
2023 |
2024 |
Growth Metrics |
- |
- |
- |
Revenue Growth |
74,422,038.71% |
43.91% |
68.56% |
EBITDA Growth |
118.64% |
-21.42% |
-71.15% |
EBIT Growth |
121.88% |
-31.25% |
-103.68% |
NOPAT Growth |
106.59% |
-36.58% |
-103.00% |
Net Income Growth |
104.47% |
-72.10% |
-375.81% |
EPS Growth |
0.00% |
-74.60% |
-312.50% |
Operating Cash Flow Growth |
964.76% |
-698.92% |
-226.04% |
Free Cash Flow Firm Growth |
0.00% |
-176.97% |
-120.93% |
Invested Capital Growth |
-82.27% |
438.44% |
164.61% |
Revenue Q/Q Growth |
127.42% |
-7.10% |
16.07% |
EBITDA Q/Q Growth |
18.50% |
-23.43% |
-59.18% |
EBIT Q/Q Growth |
19.04% |
-29.43% |
-107.37% |
NOPAT Q/Q Growth |
22.44% |
-28.92% |
-120.21% |
Net Income Q/Q Growth |
23.20% |
-60.65% |
-103.03% |
EPS Q/Q Growth |
0.00% |
0.00% |
-54.55% |
Operating Cash Flow Q/Q Growth |
258.75% |
-93.23% |
-59.25% |
Free Cash Flow Firm Q/Q Growth |
0.00% |
-25.80% |
-232.54% |
Invested Capital Q/Q Growth |
-25.25% |
6.66% |
83.34% |
Profitability Metrics |
- |
- |
- |
EBITDA Margin |
76.07% |
41.53% |
7.11% |
EBIT Margin |
76.06% |
36.33% |
-0.79% |
Profit (Net Income) Margin |
70.19% |
13.61% |
-22.26% |
Tax Burden Percent |
97.33% |
86.02% |
128.22% |
Interest Burden Percent |
94.82% |
43.53% |
2,187.69% |
Effective Tax Rate |
2.67% |
13.98% |
0.00% |
Return on Invested Capital (ROIC) |
17.47% |
11.52% |
-0.11% |
ROIC Less NNEP Spread (ROIC-NNEP) |
15.21% |
-2.42% |
-9.45% |
Return on Net Nonoperating Assets (RNNOA) |
1.31% |
-2.12% |
-8.37% |
Return on Equity (ROE) |
18.78% |
9.40% |
-8.48% |
Cash Return on Invested Capital (CROIC) |
157.22% |
-125.83% |
-90.40% |
Operating Return on Assets (OROA) |
17.33% |
12.34% |
-0.15% |
Return on Assets (ROA) |
15.99% |
4.62% |
-4.13% |
Return on Common Equity (ROCE) |
-0.05% |
9.35% |
-8.50% |
Return on Equity Simple (ROE_SIMPLE) |
118.85% |
5.51% |
-5.87% |
Net Operating Profit after Tax (NOPAT) |
33 |
21 |
-0.62 |
NOPAT Margin |
70.92% |
31.25% |
-0.56% |
Net Nonoperating Expense Percent (NNEP) |
2.26% |
13.94% |
9.33% |
SG&A Expenses to Revenue |
5.63% |
7.39% |
8.10% |
Operating Expenses to Revenue |
23.94% |
63.67% |
100.79% |
Earnings before Interest and Taxes (EBIT) |
35 |
24 |
-0.89 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
35 |
28 |
7.96 |
Valuation Ratios |
- |
- |
- |
Price to Book Value (P/BV) |
6.84 |
3.73 |
1.38 |
Price to Tangible Book Value (P/TBV) |
6.84 |
0.00 |
5.51 |
Price to Revenue (P/Rev) |
4.04 |
9.22 |
5.22 |
Price to Earnings (P/E) |
5.88 |
64.30 |
0.00 |
Dividend Yield |
0.00% |
0.00% |
0.00% |
Earnings Yield |
17.00% |
1.56% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
3.29 |
2.39 |
1.04 |
Enterprise Value to Revenue (EV/Rev) |
4.02 |
10.94 |
7.44 |
Enterprise Value to EBITDA (EV/EBITDA) |
5.29 |
26.34 |
104.64 |
Enterprise Value to EBIT (EV/EBIT) |
5.29 |
30.11 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
5.67 |
35.00 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
17.35 |
0.00 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
0.63 |
0.00 |
0.00 |
Leverage & Solvency |
- |
- |
- |
Debt to Equity |
1.01 |
0.85 |
0.90 |
Long-Term Debt to Equity |
1.00 |
0.77 |
0.81 |
Financial Leverage |
0.09 |
0.87 |
0.89 |
Leverage Ratio |
1.17 |
2.03 |
2.05 |
Compound Leverage Factor |
1.11 |
0.89 |
44.92 |
Debt to Total Capital |
50.12% |
46.01% |
47.36% |
Short-Term Debt to Total Capital |
0.07% |
4.29% |
4.78% |
Long-Term Debt to Total Capital |
50.05% |
41.72% |
42.58% |
Preferred Equity to Total Capital |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
1.59% |
0.05% |
-0.11% |
Common Equity to Total Capital |
48.28% |
53.94% |
52.75% |
Debt to EBITDA |
0.81 |
5.07 |
47.85 |
Net Debt to EBITDA |
-0.05 |
4.14 |
31.27 |
Long-Term Debt to EBITDA |
0.80 |
4.60 |
43.02 |
Debt to NOPAT |
0.86 |
6.74 |
-612.43 |
Net Debt to NOPAT |
-0.05 |
5.50 |
-400.24 |
Long-Term Debt to NOPAT |
0.86 |
6.11 |
-550.63 |
Noncontrolling Interest Sharing Ratio |
100.29% |
0.54% |
-0.12% |
Liquidity Ratios |
- |
- |
- |
Cash Flow Metrics |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
295 |
-227 |
-501 |
Operating Cash Flow to CapEx |
0.00% |
-33,765.51% |
-26,558.24% |
Free Cash Flow to Firm to Interest Expense |
6,882.25 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
249.85 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
249.85 |
0.00 |
0.00 |
Efficiency Ratios |
- |
- |
- |
Asset Turnover |
0.23 |
0.34 |
0.19 |
Fixed Asset Turnover |
0.00 |
316.70 |
157.00 |
Capital & Investment Metrics |
- |
- |
- |
Invested Capital |
56 |
304 |
804 |
Invested Capital Turnover |
0.25 |
0.37 |
0.20 |
Increase / (Decrease) in Invested Capital |
-262 |
247 |
500 |
Enterprise Value (EV) |
186 |
726 |
833 |
Market Capitalization |
186 |
612 |
585 |
Book Value per Share |
$1.49 |
$2.59 |
$5.68 |
Tangible Book Value per Share |
$1.49 |
($0.09) |
$1.42 |
Total Capital |
56 |
304 |
804 |
Total Debt |
28 |
140 |
381 |
Total Long-Term Debt |
28 |
127 |
342 |
Net Debt |
-1.76 |
114 |
249 |
Capital Expenditures (CapEx) |
0.00 |
0.19 |
0.79 |
Net Nonoperating Expense (NNE) |
0.34 |
12 |
24 |
Net Nonoperating Obligations (NNO) |
28 |
140 |
381 |
Total Depreciation and Amortization (D&A) |
0.00 |
3.45 |
8.85 |
Earnings Adjustments |
- |
- |
- |
Adjusted Basic Earnings per Share |
$0.00 |
$0.00 |
($0.34) |
Adjusted Weighted Average Basic Shares Outstanding |
32.26M |
0.00 |
70.76M |
Adjusted Diluted Earnings per Share |
$0.00 |
$0.00 |
($0.34) |
Adjusted Weighted Average Diluted Shares Outstanding |
32.26M |
0.00 |
70.76M |
Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
0.00 |
0.00 |
96.85M |
Normalized Net Operating Profit after Tax (NOPAT) |
34 |
20 |
-0.46 |
Normalized NOPAT Margin |
73.12% |
29.48% |
-0.41% |
Pre Tax Income Margin |
72.12% |
15.82% |
-17.36% |
Debt Service Ratios |
- |
- |
- |
EBIT to Interest Expense |
819.98 |
0.00 |
0.00 |
NOPAT to Interest Expense |
764.60 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
819.98 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
764.60 |
0.00 |
0.00 |
Payout Ratios |
- |
- |
- |
Dividend Payout Ratio |
21.82% |
263.34% |
-4.68% |
Augmented Payout Ratio |
21.82% |
277.54% |
-47.78% |
Quarterly Metrics And Ratios for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
This table displays calculated financial ratios and metrics derived from Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's official financial filings.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Revenue Growth |
|
62,578,810.53% |
99,433,800.00% |
58,756,900.00% |
39.70% |
96.10% |
-19.64% |
105.22% |
149.56% |
25.79% |
52.14% |
105.42% |
EBITDA Growth |
|
8.76% |
140.70% |
-17.68% |
61.32% |
-6.57% |
-90.07% |
-45.00% |
4.79% |
-3.49% |
-1,741.53% |
552.43% |
EBIT Growth |
|
8.75% |
149.47% |
-17.40% |
61.34% |
-23.11% |
-107.40% |
-67.99% |
-19.70% |
-5.46% |
-2,538.99% |
833.23% |
NOPAT Growth |
|
1.48% |
446.52% |
-11.85% |
36.58% |
-30.51% |
-114.07% |
-80.85% |
-74.27% |
-33.10% |
-939.75% |
830.79% |
Net Income Growth |
|
-3.79% |
417.21% |
-18.75% |
32.19% |
-89.85% |
-184.17% |
-116.73% |
-90.31% |
-602.85% |
-198.66% |
523.30% |
EPS Growth |
|
0.00% |
0.00% |
0.00% |
44.44% |
-95.00% |
0.00% |
-112.50% |
-92.31% |
-800.00% |
-85.71% |
350.00% |
Operating Cash Flow Growth |
|
-302.73% |
5,117.48% |
-6,093.54% |
-369.37% |
-621.86% |
-180.82% |
113.04% |
-218.39% |
-340.54% |
-565.98% |
-2,549.63% |
Free Cash Flow Firm Growth |
|
821.02% |
0.00% |
4,963.96% |
624.49% |
-180.38% |
-192.12% |
-204.27% |
-349.83% |
26.38% |
-105.95% |
-27.42% |
Invested Capital Growth |
|
-76.17% |
-82.27% |
-95.30% |
-22.44% |
277.35% |
438.44% |
2,181.07% |
80.08% |
53.94% |
164.61% |
125.44% |
Revenue Q/Q Growth |
|
41.57% |
117.43% |
-59.09% |
10.94% |
98.72% |
-10.89% |
-6.38% |
34.90% |
0.17% |
7.77% |
39.64% |
EBITDA Q/Q Growth |
|
107.10% |
-15.21% |
-17.59% |
11.48% |
19.94% |
-90.99% |
-0.84% |
112.42% |
10.47% |
-253.27% |
272.10% |
EBIT Q/Q Growth |
|
107.12% |
-15.21% |
-17.59% |
11.48% |
-1.28% |
-108.16% |
-7.03% |
179.64% |
16.22% |
-327.87% |
214.90% |
NOPAT Q/Q Growth |
|
97.95% |
-22.27% |
2.74% |
-13.61% |
0.72% |
-115.74% |
152.18% |
16.12% |
161.81% |
-344.70% |
225.12% |
Net Income Q/Q Growth |
|
103.60% |
-26.98% |
0.84% |
-11.82% |
-84.37% |
-705.61% |
79.96% |
151.10% |
-910.87% |
-259.70% |
128.40% |
EPS Q/Q Growth |
|
122.22% |
0.00% |
0.00% |
-18.75% |
-92.31% |
-1,500.00% |
85.71% |
150.00% |
-800.00% |
-271.43% |
119.23% |
Operating Cash Flow Q/Q Growth |
|
63.22% |
1,139.35% |
-201.71% |
-20.73% |
43.44% |
-16.37% |
116.99% |
-3,046.89% |
21.74% |
-75.93% |
33.04% |
Free Cash Flow Firm Q/Q Growth |
|
1,748.30% |
7.24% |
18.77% |
-75.02% |
-352.59% |
-22.92% |
-33.42% |
40.14% |
25.56% |
-243.84% |
16.83% |
Invested Capital Q/Q Growth |
|
-76.77% |
-25.25% |
-72.72% |
1,537.42% |
13.03% |
6.66% |
15.55% |
29.27% |
-3.38% |
83.34% |
-1.55% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBITDA Margin |
|
92.92% |
36.24% |
73.00% |
73.35% |
44.27% |
4.48% |
19.56% |
30.80% |
33.97% |
-48.31% |
59.54% |
EBIT Margin |
|
92.91% |
36.23% |
72.99% |
73.34% |
36.43% |
-3.34% |
11.38% |
23.60% |
27.38% |
-57.90% |
47.64% |
Profit (Net Income) Margin |
|
87.09% |
29.25% |
72.09% |
57.30% |
4.51% |
-30.64% |
-5.88% |
2.23% |
-18.02% |
-60.14% |
12.23% |
Tax Burden Percent |
|
96.71% |
94.31% |
109.42% |
85.02% |
16.68% |
59.63% |
1,250.98% |
27.05% |
95.48% |
117.30% |
69.82% |
Interest Burden Percent |
|
96.92% |
85.60% |
90.27% |
91.90% |
74.16% |
1,539.16% |
-4.13% |
34.87% |
-68.92% |
88.55% |
36.78% |
Effective Tax Rate |
|
3.29% |
0.00% |
-9.42% |
14.98% |
27.15% |
0.00% |
0.00% |
72.95% |
0.00% |
0.00% |
30.18% |
Return on Invested Capital (ROIC) |
|
8.97% |
7.64% |
25.76% |
12.62% |
12.19% |
-2.00% |
2.89% |
1.60% |
4.36% |
-7.50% |
7.83% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
10.25% |
4.57% |
8.43% |
11.77% |
2.31% |
-8.23% |
-0.09% |
0.78% |
-2.37% |
-10.29% |
4.41% |
Return on Net Nonoperating Assets (RNNOA) |
|
0.17% |
0.40% |
0.18% |
2.22% |
1.21% |
-7.20% |
-0.10% |
0.54% |
-1.68% |
-9.13% |
3.97% |
Return on Equity (ROE) |
|
9.14% |
8.03% |
25.93% |
14.84% |
13.40% |
-9.20% |
2.79% |
2.14% |
2.68% |
-16.62% |
11.81% |
Cash Return on Invested Capital (CROIC) |
|
0.00% |
157.22% |
200.07% |
36.93% |
-100.00% |
-125.83% |
-183.01% |
-55.72% |
-41.63% |
-90.40% |
-74.90% |
Operating Return on Assets (OROA) |
|
8.44% |
8.25% |
22.05% |
14.14% |
12.87% |
-1.13% |
4.08% |
5.61% |
6.76% |
-10.75% |
10.40% |
Return on Assets (ROA) |
|
7.91% |
6.66% |
21.78% |
11.05% |
1.59% |
-10.41% |
-2.11% |
0.53% |
-4.45% |
-11.16% |
2.67% |
Return on Common Equity (ROCE) |
|
-1.35% |
-0.02% |
-2.96% |
4.28% |
7.83% |
-9.15% |
2.32% |
2.14% |
2.68% |
-16.65% |
11.71% |
Return on Equity Simple (ROE_SIMPLE) |
|
-95.66% |
0.00% |
-156.94% |
20.15% |
13.85% |
0.00% |
0.08% |
-2.31% |
-4.76% |
0.00% |
-4.24% |
Net Operating Profit after Tax (NOPAT) |
|
10 |
8.02 |
8.24 |
7.12 |
7.17 |
-1.13 |
1.58 |
1.83 |
4.79 |
-12 |
15 |
NOPAT Margin |
|
86.75% |
31.01% |
77.89% |
60.66% |
30.74% |
-5.43% |
7.27% |
6.25% |
16.35% |
-37.12% |
33.26% |
Net Nonoperating Expense Percent (NNEP) |
|
-1.27% |
3.06% |
17.33% |
0.86% |
9.89% |
6.23% |
2.98% |
0.82% |
6.73% |
2.80% |
3.43% |
SG&A Expenses to Revenue |
|
0.13% |
0.00% |
6.89% |
5.83% |
7.31% |
8.61% |
8.89% |
8.72% |
7.40% |
7.63% |
5.93% |
Operating Expenses to Revenue |
|
7.09% |
63.77% |
27.01% |
26.66% |
63.57% |
103.34% |
88.62% |
76.40% |
72.62% |
157.90% |
52.36% |
Earnings before Interest and Taxes (EBIT) |
|
11 |
9.37 |
7.72 |
8.61 |
8.49 |
-0.69 |
2.47 |
6.91 |
8.03 |
-18 |
21 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
11 |
9.37 |
7.72 |
8.61 |
10 |
0.93 |
4.25 |
9.02 |
9.96 |
-15 |
26 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.00 |
6.84 |
0.00 |
0.72 |
2.59 |
3.73 |
4.70 |
2.15 |
2.93 |
1.38 |
1.68 |
Price to Tangible Book Value (P/TBV) |
|
0.00 |
6.84 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
6.11 |
8.08 |
5.51 |
6.19 |
Price to Revenue (P/Rev) |
|
21.36 |
4.04 |
3.32 |
1.92 |
6.02 |
9.22 |
10.65 |
6.12 |
7.83 |
5.22 |
5.39 |
Price to Earnings (P/E) |
|
16.98 |
5.88 |
6.19 |
3.55 |
18.40 |
64.30 |
9,417.59 |
0.00 |
0.00 |
0.00 |
0.00 |
Dividend Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Earnings Yield |
|
5.89% |
17.00% |
16.16% |
28.18% |
5.43% |
1.56% |
0.01% |
0.00% |
0.00% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
|
5.78 |
3.29 |
12.57 |
0.74 |
1.80 |
2.39 |
2.55 |
1.45 |
2.09 |
1.04 |
1.32 |
Enterprise Value to Revenue (EV/Rev) |
|
21.51 |
4.02 |
3.41 |
3.10 |
7.17 |
10.94 |
12.30 |
7.29 |
9.51 |
7.44 |
7.75 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
14.74 |
5.29 |
5.79 |
5.06 |
14.23 |
26.34 |
46.10 |
33.19 |
47.01 |
104.64 |
34.51 |
Enterprise Value to EBIT (EV/EBIT) |
|
14.80 |
5.29 |
5.78 |
5.06 |
14.99 |
30.11 |
63.05 |
52.64 |
76.02 |
0.00 |
58.29 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
16.33 |
5.67 |
6.26 |
5.54 |
17.55 |
35.00 |
2,552.08 |
127.52 |
297.95 |
0.00 |
83.28 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
17.35 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.63 |
0.56 |
1.75 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Debt to Equity |
|
0.07 |
1.01 |
0.57 |
0.57 |
0.72 |
0.85 |
1.12 |
0.77 |
0.70 |
0.90 |
0.82 |
Long-Term Debt to Equity |
|
0.00 |
1.00 |
0.00 |
0.57 |
0.72 |
0.77 |
1.03 |
0.59 |
0.65 |
0.81 |
0.55 |
Financial Leverage |
|
0.02 |
0.09 |
0.02 |
0.19 |
0.52 |
0.87 |
1.09 |
0.69 |
0.71 |
0.89 |
0.90 |
Leverage Ratio |
|
1.16 |
1.17 |
1.12 |
1.28 |
1.71 |
2.03 |
2.32 |
1.82 |
1.84 |
2.05 |
2.05 |
Compound Leverage Factor |
|
1.12 |
1.01 |
1.01 |
1.18 |
1.27 |
31.30 |
-0.10 |
0.64 |
-1.27 |
1.82 |
0.75 |
Debt to Total Capital |
|
6.52% |
50.12% |
36.22% |
36.33% |
41.70% |
46.01% |
52.91% |
43.42% |
41.19% |
47.36% |
44.98% |
Short-Term Debt to Total Capital |
|
6.52% |
0.07% |
36.22% |
0.16% |
0.00% |
4.29% |
4.46% |
10.08% |
3.22% |
4.78% |
14.92% |
Long-Term Debt to Total Capital |
|
0.00% |
50.05% |
0.00% |
36.17% |
41.70% |
41.72% |
48.46% |
33.33% |
37.97% |
42.58% |
30.06% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
129.88% |
1.59% |
190.55% |
0.14% |
0.10% |
0.05% |
0.06% |
0.02% |
-0.02% |
-0.11% |
0.62% |
Common Equity to Total Capital |
|
-36.40% |
48.28% |
-126.77% |
63.53% |
58.19% |
53.94% |
47.03% |
56.57% |
58.83% |
52.75% |
54.40% |
Debt to EBITDA |
|
0.17 |
0.81 |
0.17 |
2.49 |
3.30 |
5.07 |
9.56 |
9.92 |
9.27 |
47.85 |
11.79 |
Net Debt to EBITDA |
|
-3.21 |
-0.05 |
-0.71 |
1.92 |
2.28 |
4.14 |
6.19 |
5.33 |
8.27 |
31.27 |
10.34 |
Long-Term Debt to EBITDA |
|
0.00 |
0.80 |
0.00 |
2.48 |
3.30 |
4.60 |
8.75 |
7.62 |
8.54 |
43.02 |
7.88 |
Debt to NOPAT |
|
0.18 |
0.86 |
0.18 |
2.73 |
4.07 |
6.74 |
528.99 |
38.13 |
58.72 |
-612.43 |
28.44 |
Net Debt to NOPAT |
|
-3.56 |
-0.05 |
-0.77 |
2.10 |
2.81 |
5.50 |
342.84 |
20.46 |
52.41 |
-400.24 |
24.94 |
Long-Term Debt to NOPAT |
|
0.00 |
0.86 |
0.00 |
2.71 |
4.07 |
6.11 |
484.44 |
29.28 |
54.13 |
-550.63 |
19.01 |
Noncontrolling Interest Sharing Ratio |
|
114.82% |
100.29% |
111.42% |
71.13% |
41.56% |
0.54% |
16.87% |
0.10% |
0.05% |
-0.12% |
0.85% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
252 |
270 |
320 |
80 |
-202 |
-249 |
-334 |
-200 |
-149 |
-512 |
-426 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
-12,270.86% |
-14,858.81% |
1,401.30% |
-35,324.72% |
-21,557.08% |
-47,714.70% |
-27,450.38% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
6,304.99 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
|
0.00 |
399.28 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
399.28 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Asset Turnover |
|
0.09 |
0.23 |
0.30 |
0.19 |
0.35 |
0.34 |
0.36 |
0.24 |
0.25 |
0.19 |
0.22 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
316.70 |
0.00 |
207.81 |
167.65 |
157.00 |
155.56 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Invested Capital |
|
76 |
56 |
15 |
252 |
285 |
304 |
351 |
454 |
439 |
804 |
792 |
Invested Capital Turnover |
|
0.10 |
0.25 |
0.33 |
0.21 |
0.40 |
0.37 |
0.40 |
0.26 |
0.27 |
0.20 |
0.24 |
Increase / (Decrease) in Invested Capital |
|
-241 |
-262 |
-312 |
-73 |
209 |
247 |
336 |
202 |
154 |
500 |
440 |
Enterprise Value (EV) |
|
436 |
186 |
193 |
186 |
512 |
726 |
896 |
659 |
917 |
833 |
1,043 |
Market Capitalization |
|
433 |
186 |
188 |
115 |
430 |
612 |
776 |
553 |
755 |
585 |
725 |
Book Value per Share |
|
($0.64) |
$1.49 |
($1.06) |
$13.95 |
$2.63 |
$2.59 |
$2.59 |
$4.02 |
$3.46 |
$5.68 |
$4.45 |
Tangible Book Value per Share |
|
($0.64) |
$1.49 |
($1.06) |
($1.14) |
($0.09) |
($0.09) |
($0.05) |
$1.42 |
$1.25 |
$1.42 |
$1.21 |
Total Capital |
|
76 |
56 |
15 |
252 |
285 |
304 |
351 |
454 |
439 |
804 |
792 |
Total Debt |
|
4.92 |
28 |
5.58 |
92 |
119 |
140 |
186 |
197 |
181 |
381 |
356 |
Total Long-Term Debt |
|
0.00 |
28 |
0.00 |
91 |
119 |
127 |
170 |
151 |
167 |
342 |
238 |
Net Debt |
|
-95 |
-1.76 |
-24 |
70 |
82 |
114 |
120 |
106 |
161 |
249 |
312 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.10 |
0.09 |
0.16 |
0.19 |
0.24 |
0.19 |
0.22 |
Net Nonoperating Expense (NNE) |
|
-0.04 |
0.46 |
0.61 |
0.39 |
6.12 |
5.24 |
2.85 |
1.18 |
10 |
7.28 |
9.28 |
Net Nonoperating Obligations (NNO) |
|
4.92 |
28 |
5.58 |
92 |
119 |
140 |
186 |
197 |
181 |
381 |
356 |
Total Depreciation and Amortization (D&A) |
|
0.00 |
0.00 |
0.00 |
0.00 |
1.83 |
1.62 |
1.77 |
2.11 |
1.93 |
3.03 |
5.25 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.13 |
$0.01 |
($0.13) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Adjusted Weighted Average Basic Shares Outstanding |
|
24.81M |
50.37M |
14.13M |
50.51M |
63.35M |
56.95M |
63.03M |
63.85M |
74.69M |
70.76M |
96.19M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.13 |
$0.01 |
($0.14) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
24.81M |
50.37M |
14.13M |
50.51M |
63.35M |
57.77M |
63.03M |
67.16M |
74.69M |
70.76M |
97.50M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
18.34M |
0.00 |
11.48M |
62.96M |
63.35M |
63.69M |
63.93M |
74.65M |
74.68M |
96.85M |
96.85M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
11 |
5.61 |
5.18 |
6.54 |
7.39 |
-1.74 |
0.76 |
4.99 |
4.50 |
-11 |
14 |
Normalized NOPAT Margin |
|
88.76% |
21.71% |
49.00% |
55.78% |
31.70% |
-8.39% |
3.51% |
17.05% |
15.35% |
-33.89% |
32.83% |
Pre Tax Income Margin |
|
90.06% |
31.01% |
65.89% |
67.40% |
27.02% |
-51.37% |
-0.47% |
8.23% |
-18.87% |
-51.27% |
17.52% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
0.00 |
218.87 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT to Interest Expense |
|
0.00 |
187.34 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
|
0.00 |
218.87 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
|
0.00 |
187.34 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
0.00% |
21.82% |
0.00% |
87.40% |
119.89% |
263.34% |
0.00% |
-23.89% |
-9.49% |
-4.68% |
0.00% |
Augmented Payout Ratio |
|
0.00% |
21.82% |
0.00% |
87.40% |
119.89% |
277.54% |
6,561.95% |
-226.41% |
-107.47% |
-47.78% |
-17.64% |
Key Financial Trends
Abacus Life (NASDAQ: ABL) has shown notable financial performance trends over the last several years through Q1 2025, reflecting both significant growth and periods of challenge. Here are the key takeaways for retail investors assessing the company’s recent financial health:
- Strong Recent Earnings: In Q1 2025, ABL reported consolidated net income of approximately $5.4 million, a significant turnaround from losses in 2024 quarters, indicating improving profitability.
- Revenue Growth: Total revenue in Q1 2025 reached $44.1 million, up notably from $21.7 million in Q1 2024, driven by increased non-interest income such as service charges and other fees.
- Operating Margin Improvement: Total non-interest expenses in Q1 2025 were $23.1 million compared to $19.2 million in Q1 2024, but the sharp rise in revenue contributed to a positive pre-tax income of $7.7 million, an improvement from a near break-even in previous year’s same quarter.
- Increase in Equity Base: Common equity rose to $430.7 million as of Q1 2025, up from $165.1 million in Q1 2024, indicating capital strengthening and support for growth.
- Stable Share Count: Weighted average diluted shares outstanding have increased, but steadily, to about 97 million shares in Q1 2025, providing a consistent basis for earnings per share calculation.
- Negative Operating Cash Flow: Despite profitability, net cash from operating activities was negative $61.6 million in Q1 2025, reflecting working capital changes and non-cash adjustments that warrant further scrutiny.
- Heavy Debt Burden: Total liabilities remain substantial at $420.9 million as of Q1 2025, largely from long-term debt of about $238 million, which could pressure cash flow given interest payments.
- Volatile Nonoperating Expense: Non-operating expenses were -$13.3 million in Q1 2025, significantly impacting pre-tax earnings and suggesting risks from non-core operations or investments.
- Historical Losses and Volatility: ABL experienced considerable net losses throughout much of 2023 and 2024, with negative net income visible in several quarters, including a loss of $19 million in Q4 2024, indicating past operational challenges.
- Negative Retained Earnings: Retained earnings remained negative, around -$53 million as of Q1 2025, showing accumulated deficits which may affect shareholder value and dividend capacity.
Overall, Abacus Life has demonstrated a return to profitability in early 2025 with encouraging revenue gains and improved equity levels. However, investors should monitor the company’s operating cash flow situation, high debt levels, and past losses as potential risks. The management’s ability to maintain profitability and convert earnings into cash flow will be key to sustaining the positive momentum.
08/02/25 07:03 AMAI Generated. May Contain Errors.